SE9701228D0 - Rekombinanta protein-C-och protein-S-varianter - Google Patents

Rekombinanta protein-C-och protein-S-varianter

Info

Publication number
SE9701228D0
SE9701228D0 SE9701228A SE9701228A SE9701228D0 SE 9701228 D0 SE9701228 D0 SE 9701228D0 SE 9701228 A SE9701228 A SE 9701228A SE 9701228 A SE9701228 A SE 9701228A SE 9701228 D0 SE9701228 D0 SE 9701228D0
Authority
SE
Sweden
Prior art keywords
protein
component
wild
amino acid
variants
Prior art date
Application number
SE9701228A
Other languages
English (en)
Inventor
Bjoern Dahlbaeck
Original Assignee
Bjoern Dahlbaeck
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bjoern Dahlbaeck filed Critical Bjoern Dahlbaeck
Priority to SE9701228A priority Critical patent/SE9701228D0/sv
Publication of SE9701228D0 publication Critical patent/SE9701228D0/sv
Priority to EP98915077A priority patent/EP0996637A1/en
Priority to JP54152998A priority patent/JP2002501373A/ja
Priority to PCT/SE1998/000490 priority patent/WO1998044000A1/en
Priority to NZ337800A priority patent/NZ337800A/xx
Priority to CA002283934A priority patent/CA2283934A1/en
Priority to AU69345/98A priority patent/AU741798B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9701228A 1997-04-03 1997-04-03 Rekombinanta protein-C-och protein-S-varianter SE9701228D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9701228A SE9701228D0 (sv) 1997-04-03 1997-04-03 Rekombinanta protein-C-och protein-S-varianter
EP98915077A EP0996637A1 (en) 1997-04-03 1998-03-18 Recombinant protein c and protein s variants
JP54152998A JP2002501373A (ja) 1997-04-03 1998-03-18 組換えプロテインｃ及びプロテインｓ変異体
PCT/SE1998/000490 WO1998044000A1 (en) 1997-04-03 1998-03-18 Recombinant protein c and protein s variants
NZ337800A NZ337800A (en) 1997-04-03 1998-03-18 Recombinant protein C and protein S variants
CA002283934A CA2283934A1 (en) 1997-04-03 1998-03-18 Recombinant protein c and protein s variants
AU69345/98A AU741798B2 (en) 1997-04-03 1998-03-18 Recombinant protein C and protein S variants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9701228A SE9701228D0 (sv) 1997-04-03 1997-04-03 Rekombinanta protein-C-och protein-S-varianter

Publications (1)

Publication Number Publication Date
SE9701228D0 true SE9701228D0 (sv) 1997-04-03

Family

ID=20406428

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9701228A SE9701228D0 (sv) 1997-04-03 1997-04-03 Rekombinanta protein-C-och protein-S-varianter

Country Status (7)

Country Link
EP (1) EP0996637A1 (sv)
JP (1) JP2002501373A (sv)
AU (1) AU741798B2 (sv)
CA (1) CA2283934A1 (sv)
NZ (1) NZ337800A (sv)
SE (1) SE9701228D0 (sv)
WO (1) WO1998044000A1 (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6998122B1 (en) 1999-04-30 2006-02-14 Eli Lilly And Company Protein C derivatives
DE60108076T2 (de) 2000-02-02 2006-03-16 Eli Lilly And Co., Indianapolis Protein c derivate
US6630138B2 (en) 2000-02-11 2003-10-07 Eli Lilly And Company Protein C derivatives
US6933367B2 (en) 2000-10-18 2005-08-23 Maxygen Aps Protein C or activated protein C-like molecules
AU2003212739B2 (en) * 2002-03-01 2008-01-17 T.A.C. Thrombosis And Coagulation Aktiebolag Recombinant protein C variants
WO2003106666A2 (en) * 2002-06-14 2003-12-24 Maxygen Aps Protein c variants with altered properties
WO2023119230A1 (en) 2021-12-22 2023-06-29 L'oreal Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE464135B (sv) * 1989-07-14 1991-03-11 Kabivitrum Ab Foerfarande foer bestaemning av funktionell aktivitet av fritt protein s eller protein c i ett plasmaprov
IL97311A0 (en) * 1990-02-23 1992-05-25 Lilly Co Eli Vectors and compounds for expression of glycosylation mutants of human protein c
US5405946A (en) * 1992-12-02 1995-04-11 The Scripps Research Institute Recombinant protein S variants deficient in C4BP binding activity, compositions and therapeutic methods
JPH08511948A (ja) * 1993-06-30 1996-12-17 リークスウニフエルジタイト・ライデン Ｃ４ｂｐ結合活性が不足しているがａｐｃ補因子活性を有するプロテインｓ欠失変異体、組成物及び治療法

Also Published As

Publication number Publication date
JP2002501373A (ja) 2002-01-15
WO1998044000A1 (en) 1998-10-08
AU741798B2 (en) 2001-12-13
EP0996637A1 (en) 2000-05-03
NZ337800A (en) 2001-03-30
AU6934598A (en) 1998-10-22
CA2283934A1 (en) 1998-10-08

Similar Documents

Publication Publication Date Title
RU95115239A (ru) Аналог эритропоэтина
DE69934967D1 (de) Verfahren zur verminderung der immunogenität von proteinen
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
ATE451390T1 (de) Polypeptide zur bindung an das b-lymphozyten- stimulatorische protein (blys)
SE8902532D0 (sv) Bestaemning av plasmaproteiner
DE3587875T2 (de) Rekombinantverfahren zur herstellung von serinproteaseinhibitoren, sowie dns-sequenzen dazu.
NO881670L (no) Diagnostisk proeve paa inhibitor for plasminogenaktivatorerav vev- og urokinasetype, samt gen som koder for inhibitoren.
BR9811592A (pt) Oxidase de citocinina
SE9701228D0 (sv) Rekombinanta protein-C-och protein-S-varianter
WO2002010357A3 (en) Gsk3 polypeptides
WO1998011234A3 (en) Human protein kinases
WO2005017188A3 (en) Fusion proteins with a membrane translocating sequence and methods of using same to inhibit an immune response
DE69132889T2 (de) Überlegende thrombomodulinanaloga zur pharmazeutischen verwendung
WO2003073980A3 (en) Recombinant protein c variants
ATE510911T1 (de) Prothrombin aktivierendes protein
ATE254663T1 (de) Erhöhte produktion von sekretierten proteinen durch rekombinante eukaryotische zellen
DE69738600D1 (de) Neuroaktive peptide
DK0616642T3 (da) Hidtil ukendte thrombininhibitoriske proteiner fra landblodigler
FR2773079B1 (fr) Cible de traitement de l'atherosclerose, de l'obesite et du diabete de type ii
BRPI0308978A8 (pt) fragmentos de peptídeos sintéticos ativos
NO962596L (no) Nytt tumorsupressorgen
ATE312914T1 (de) Rdgb-proteine
WO2002088180A3 (en) Use of alpha 1-antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds
KR950003312A (ko) 연골세포 단백질
WO2004099408A8 (ja) 新規蛋白質およびそれをコードするｄｎａ